Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain

Objective: Fixed-dose combinations of antiretroviral drugs have meant an important step forward in simplifying treatment and improving com-pliance and has led to an increased effectiveness of therapy, a viral load decrease and improving the quality of life of patients.The single-table formulation o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Farmacia Hospitalaria
Auteurs principaux: Santiago Moreno Guillén, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefehain, David López Sánchez-Cambronero, Francisco Javier Parrondo García
Format: Artigo
Langue:Inglês
Publié: Sociedad Española de Farmacia Hospitalaria 2017
Sujets:
Medicina
Cost
HIV treatment
Utility analysis
Computer simulation
Accès en ligne:https://www.redalyc.org/articulo.oa?id=365962297005
https://www.redalyc.org/journal/3659/365962297005/
https://www.redalyc.org/journal/3659/365962297005/html/
https://www.redalyc.org/journal/3659/365962297005/365962297005.epub
https://www.redalyc.org/journal/3659/365962297005/movil
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires